Skip to main navigation Skip to search Skip to main content

Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma

  • K.A. Frerichs
  • , M.C. Minnema
  • , M.D. Levin
  • , A. Broijl
  • , G.M.J. Bos
  • , M.J. Kersten
  • , T. Mutis
  • , C.P.M. Verkleij
  • , I.S. Nijhof
  • , P.W.C. Maas-Bosman
  • , S.K. Klein
  • , S. Zweegman
  • , P. Sonneveld
  • , N.W.C.J. van de Donk*
    • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma'. Together they form a unique fingerprint.
Sort by

Keyphrases

INIS

Immunology and Microbiology